Another study demonstrated that the combination of CAR-T cells and modified OVs expressing TNF-α and IL-2 has a robust anti-tumor effect in the pancreatic ductal adenocarcinoma (PDA) murine model [48]. Here, IL2 is linked to neoplasm.